CROLIUS CLAYTON (Chief Financial Officer) received a stock award from DNA X, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/10/2025ACC: 0001493152-25-005765
Officer· Chief Financial Officer
Since Jul 2022
+33.92K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
33.92K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+33.92K
Price / share
—
Trade value
—
% of position
391.3%
2/6/2025
8.67K→42.59K
Total
Net shares
+33.92K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/6/2025 | A · Award | +33.92K | — | — | 391.3% | 8.67K | 42.59K |
| Total | +33.92K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported